NCT00049023View on ClinicalTrials.gov

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Brain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell TumorNeuroblastomaPheochromocytomaSarcomaUnspecified Childhood Solid Tumor, Protocol Specific
Interventions
RADIATION

90Y-DOTA-tyr3-OCTREOTIDE

Trial Locations (1)

52242-1002

Holden Comprehensive Cancer Center at University of Iowa, Iowa City

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

O'Dorisio, M S

OTHER

NCT00049023 - Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors | Biotech Hunter | Biotech Hunter